Ralf-Dieter Hofheinz (R Hofheinz, Ralf Hofheinz, Ralf D Hofheinz, R-D Hofheinz)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 15

Top Topics

Diffusion Weighted

Epidermal Growth Factor Receptor

Top Venues

Gastroenterology research and practice

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Magdalena K Scheck, Ralf-Dieter Hofheinz, Sylvie Lorenzen
HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments. Cancers 16 (7) (2024)
Magdalena K Scheck, Ralf-Dieter Hofheinz, Sylvie Lorenzen
HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments. Cancers 16 (7) (2024)
Magdalena K Scheck, Ralf-Dieter Hofheinz, Sylvie Lorenzen
HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments. Cancers 16 (7) (2024)
Friedemann Schad, Anja Thronicke, Ralf-Dieter Hofheinz, Harald Matthes, Christian Grah
Patients with Advanced or Metastasised Non-Small-Cell Lung Cancer with Viscum album L. Therapy in Addition to PD-1/PD-L1 Blockade: A Real-World Data Study. Cancers 16 (8) (2024)
Friedemann Schad, Anja Thronicke, Ralf-Dieter Hofheinz, Harald Matthes, Christian Grah
Patients with Advanced or Metastasised Non-Small-Cell Lung Cancer with Viscum album L. Therapy in Addition to PD-1/PD-L1 Blockade: A Real-World Data Study. Cancers 16 (8) (2024)
Sylvie Lorenzen, Thorsten Oliver Götze, Peter C Thuss-Patience, Matthias Biebl, Nils Homann, Michael Schenk, Udo Lindig, Vera Heuer, Albrecht Kretzschmar, Eray Goekkurt, Georg Martin Haag, Jorge Riera-Knorrenschild, Claus Bolling, Ralf-Dieter Hofheinz, Tianzuo Zhan, Stefan Angermeier, Thomas Jens Ettrich, Alexander Reinhard Siebenhüner, Moustafa Elshafei, Wolf Otto Bechstein, Timo Gaiser, Maria Loose, Disorn Sookthai, Christina Kopp, Claudia Pauligk, Salah-Eddin Al-Batran, null null
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ralf-Dieter Hofheinz, Sylvie Lorenzen, Michael K Bohlmann
HER-2-Positive Tumors: A Continuously Evolving Field in Cancer Research. Cancers 15 (13) (2023)
Thorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, Harald Schmalenberg, Dirk Strumberg, Eray Goekkurt, Stefan Angermeier, Thomas Zander, Hans G Kopp, Daniel Pink, Gabriele Siegler, Michael Schenk, Ferdinando De Vita, Gennaro Galizia, Evaristo Maiello, Wolf O Bechstein, Moustafa Elshafei, Maria Loose, Disorn Sookthai, Tanita Brulin, Claudia Pauligk, Nils Homann, Salah-Eddin Al-Batran
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma - A randomized phase II/III trial of the German AIO and Italian GOIM. International journal of cancer (2023)
Anna Lena Hohneck, Largsi Sadikaj, Lara Heinemann, Maik Schroeder, Hartmut Riess, Annette Gerhards, Iris Burkholder, Stefan Heckel-Reusser, Julia Gottfried, Ralf-Dieter Hofheinz
Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia in Addition to Palliative Chemotherapy: A Retrospective Single-Center Analysis. Cancers 15 (20) (2023)
Ralf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, Christoph Springfeld, Thomas Jens Ettrich, Kersten Borchert, Albrecht Kretzschmar, Christian Teschendorf, Gabriele Siegler, Matthias P A Ebert, Eray Goekkurt, Rolf Mahlberg, Nils Homann, Daniel Pink, Wolf Bechstein, Peter Reichardt, Hagen Flach, Timo Gaiser, Achim Battmann, Fuat S Oduncu, Maria Loose, Disorn Sookthai, Claudia Pauligk, Thorsten O Göetze, Salah-Eddin Al-Batran
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (32) (2022)
Ralf-Dieter Hofheinz, Susanne Hegewisch-Becker, Volker Kunzmann, Peter Thuss-Patience, Martin Fuchs, Nils Homann, Ullrich Graeven, Nadine Schulte, Kirsten Merx, Michael Pohl, Swantje Held, Ralph Keller, Andrea Tannapfel, Salah-Eddin Al-Batran
Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group. International journal of cancer 149 (6) (2021)
Harald Matthes, Anja Thronicke, Ralf-Dieter Hofheinz, Erik Baars, David D Martin, Roman Huber, Thomas Breitkreuz, Gil Bar-Sela, Daniel Galun, Friedemann Schad
Statement to an Insufficient Systematic Review on Viscum album L. Therapy. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
U I Attenberger, J Winter, Felix N Harder, I Burkholder, D Dinter, S Kaltschmidt, P Kienle, S O Schoenberg, Ralf-Dieter Hofheinz
Height of Rectal Cancer: A Comparison between Rectoscopic and Different MRI Measurements. Gastroenterology research and practice 2020 (2020)
Melanie Kripp, Kirsten Merx, Ralph Markus Wirtz, Timo Gaiser, Sebastian Eidt, Juliana Schwaab, Stefan Post, Frederik Wenz, Andreas Hochhaus, Ralf-Dieter Hofheinz, Philipp Erben
Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer. Gastroenterology research and practice 2016 (2016)
Ralf-Dieter Hofheinz, Ulrich Ronellenfitsch, S Kubicka, A Falcone, I Burkholder, U T Hacker
Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials. Gastroenterology research and practice 2016 (2016)